GP-3.2

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGP-3.2
Drug Alias Nameanti-HLA class II mAb (GenPat)anti-HLA class II monoclonal antibody (GenPat)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionHistocompatibility antigens class II inhibitors
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsInflammationCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenPat77 Pharmacogenetics AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenPat77 Pharmacogenetics AG
Active IndicationsN/A
Inactive IndicationsInflammationCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A